TrkB receptor

TrkB receptor (also known as Tropomyosin receptor kinase B) is a protein that in humans is encoded by the NTRK2 gene. It is a member of the neurotrophic tyrosine kinase receptor (NTKR) family, which is a subfamily of the tyrosine kinase receptors. TrkB receptor plays a crucial role in neuronal plasticity, survival, and differentiation.

Function[edit | edit source]

The TrkB receptor is a high-affinity receptor for certain members of the neurotrophin family, which includes nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and neurotrophin-3 (NT-3). Upon binding to these neurotrophins, TrkB receptor undergoes autophosphorylation, which leads to the activation of several downstream signaling pathways, including the PI3K/Akt pathway, the MAPK/ERK pathway, and the PLCγ pathway. These pathways are involved in a wide range of cellular processes, such as cell survival, growth, differentiation, and synaptic plasticity.

Clinical significance[edit | edit source]

Alterations in the function or expression of TrkB receptor have been implicated in a variety of neurological disorders, including Alzheimer's disease, Parkinson's disease, depression, and schizophrenia. In addition, TrkB receptor has been found to be overexpressed in certain types of cancer, suggesting a potential role in tumor growth and progression.

Therapeutic potential[edit | edit source]

Given its role in neuronal survival and differentiation, TrkB receptor is considered a potential therapeutic target for a variety of neurological disorders. Several small molecule inhibitors of TrkB receptor have been developed and are currently being tested in preclinical and clinical trials.